ストックスクリーナーアプリを入手
17.34
3.34%
0.56
アフターアワーズ：
17.72
0.38
+2.19%
10 X Genomics Inc (TXG) 最新ニュース
10x Genomics Inc (TXG) Trading 2.45% Higher on Nov 4 - GuruFocus.com
10x Genomics (NASDAQ:TXG) Price Target Cut to $19.00 by Analysts at Barclays - MarketBeat
Earnings Update: 10x Genomics, Inc. (NASDAQ:TXG) Just Reported And Analysts Are Trimming Their Forecasts - Simply Wall St
FY2024 EPS Estimates for 10x Genomics Boosted by Analyst - MarketBeat
Allspring Global Investments Holdings LLC Has $880,000 Stake in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
TechBio Startup Cure51 Selects 10x Genomics Visium HD for New Drug Discovery Initiative - PR Newswire
10x Genomics, Inc. (NASDAQ:TXG) Q3 2024 Earnings Call Transcript - Insider Monkey
TechBio Startup Cure51 Selects 10x Genomics Visium HD for New Drug Discovery Initiative – Company Announcement - Financial Times
10x Genomics Inc (TXG) Q3 2024 Earnings Call Highlights: Navigat - GuruFocus.com
These Analysts Boost Their Forecasts On 10x Genomics After Q3 Results - Benzinga
10x Genomics Inc (TXG) Trading 4.91% Higher on Oct 30 - GuruFocus.com
UBS Group Lowers 10x Genomics (NASDAQ:TXG) Price Target to $20.00 - MarketBeat
10x Genomics (NASDAQ:TXG) Issues Earnings Results - MarketBeat
10x Genomics Inc (TXG) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... - Yahoo Finance
10x Genomics: Q3 Earnings Snapshot - The Advocate
10x Genomics (TXG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
10x Genomics falls 7% on 2024 revenue guidance cut - MSN
10x Genomics (TXG) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
10x Genomics Inc Reports Q3 2024 Revenue of $151.7 Million, Missing Estimates; Gross Margin Improves to 70% - GuruFocus.com
10x Genomics shares sink 7% on revenue miss, lowered outlook - Investing.com India
10x Genomics shares sink 7% on revenue miss, lowered outlook By Investing.com - Investing.com UK
10x Genomics, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year of 2024 - Marketscreener.com
10x Genomics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
10x Genomics Reports Third Quarter 2024 Financial Results – Company Announcement - Financial Times
Zacks Industry Outlook Medical Systems, 10x Genomics and Omnicell - Yahoo Finance
10X Genomics' SWOT analysis: stock faces headwinds amid strong consumables demand - Investing.com India
Lecap Asset Management Ltd. Purchases Shares of 38,829 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
10x Genomics (TXG) Upgraded to Strong Buy: Here's Why - Yahoo Finance
PacBio Onso™ Short Read Sequencing Instrument Joins 10x Genomics Compatible Partner Program - StockTitan
10x Genomics (TXG) Set to Announce Earnings on Tuesday - MarketBeat
Morgan Stanley spotlights 10 small-cap stocks with at least 50% upside - Kursiv Media
10x Genomics Inc.: How Are They Adapting to Market Conditions & Customer Needs?Major Drivers - Smartkarma
European Unified Patent Court Rules in Favor of Bruker and NanoString, Invalidating Patent Asserted By 10x Genomics against NanoString’s CosMx SMI Products - Yahoo Finance
Analysts Set 10x Genomics, Inc. (NASDAQ:TXG) Target Price at $30.60 - MarketBeat
SG Americas Securities LLC Sells 77,766 Shares of 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
10x Genomics Delivers 'Single Cell for a Single Cent' with New Chromium Launches - PR Newswire
Barclays Lowers 10x Genomics (NASDAQ:TXG) Price Target to $21.00 - MarketBeat
10x Genomics, Inc. to Post Q3 2024 Earnings of ($0.31) Per Share, Leerink Partnrs Forecasts (NASDAQ:TXG) - MarketBeat
10x Genomics Stock: Deciphering The Preliminary Q3 Earnings (NASDAQ:TXG) - Seeking Alpha
The Price Is Right For 10x Genomics, Inc. (NASDAQ:TXG) Even After Diving 28% - Simply Wall St
10X Genomics stock hits 52-week low at $14.91 amid market shifts - Investing.com India
10x Genomics reports dip in Q3 instrument sales, growth in consumables By Investing.com - Investing.com Australia
These Stocks Are Moving the Most Today: Tesla, Super Micro, AMD, and More - Barron's
10x Genomics reports dip in Q3 instrument sales, growth in consumables - Investing.com India
Where 10x Genomics Stands With Analysts - Benzinga
10x Genomics' (TXG) Overweight Rating Reiterated at Stephens - MarketBeat
10x Genomics (NASDAQ:TXG) PT Lowered to $20.00 - MarketBeat
10x Genomics (NASDAQ:TXG) Reaches New 1-Year LowShould You Sell? - MarketBeat
10X Genomics stock hits 52-week low at $14.91 amid market shifts By Investing.com - Investing.com South Africa
Tesla, Delta, Super Micro, 10x Genomics, Domino’s, TD Bank, and More Stock Movers - Barron's
Gene Sequencing Tech Provider 10x Genomics' Q3 Sales Fall Short On Expectations, But CEO Sees Opportunity Ahead - Benzinga
10X Genomics stock maintains Neutral rating after Q3 miss - Investing.com India
10X Genomics falls on weak preliminary Q3 revenue - XM
Dimensional Fund Advisors LP Sells 261,145 Shares of 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
10x Genomics Announces Preliminary Select Third Quarter 2024 Results - BioSpace
2.66%
0.07%
大文字化:
|
ボリューム (24 時間):